profit from every $100 of sales.
$0$100
Molina Healthcare
$209.85+0.29% today
+48.8% in 1 year
1-year low $122.651-year high $242.88
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $23.12 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Molina Healthcare sold, what it kept, and what it did with the cash.
Sales went from $32.0 billion in 2022 to $45.4 billion in 2025, with $472 million of profit last year.
SalesProfit
Molina Healthcare vs. similar companies
Molina Healthcare grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Molina Healthcare | 23.1× · Fair price | ||
 UnitedHealth | 30.1× · Expensive | ||
 CVS Health | 65.0× · Very expensive | ||
 Elevance Health | 16.4× · Fair price | ||
 The Cigna Group | 13.1× · Cheap |
AI analysis
An AI analyst reads Molina Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 19,423 | 27,771 | 31,974 | 34,072 | 40,650 | 45,426 | |
| – | – | 3,926 | 4,334 | 4,736 | 4,075 | |
| 1,078 | 1,020 | 1,381 | 1,573 | 1,707 | 781 | |
| 1,151 | 1,126 | 1,349 | 1,744 | 1,893 | 976 | |
| 673 | 659 | 792 | 1,091 | 1,179 | 472 | |
| 11.23 | 11.25 | 13.55 | 18.71 | 20.42 | 8.92 | |
| – | – | 12.3% | 12.7% | 11.7% | 9.0% | |
| 5.6% | 3.7% | 4.3% | 4.6% | 4.2% | 1.7% | |
| 3.5% | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 9,532 | 12,209 | 12,314 | 14,892 | 15,630 | 15,564 |
| Cash | 4,154 | 4,438 | 4,006 | 4,848 | 4,662 | 4,248 |
| Total debt | 2,203 | 2,307 | 2,391 | 2,385 | 3,118 | 3,950 |
| Total liabilities | 7,436 | 9,579 | 9,350 | 10,677 | 11,134 | 11,495 |
| 2,096 | 2,630 | 2,964 | 4,215 | 4,496 | 4,069 | |
| 60 | 59 | 59 | 58 | 58 | 53 | |
| 19.5% | 15.9% | 17.3% | 18.8% | 17.7% | 7.7% | |
| 32.1% | 25.1% | 26.7% | 25.9% | 26.2% | 11.6% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,898 | 2,119 | 773 | 1,662 | 644 | -535 | |
| 74 | 77 | 91 | 84 | 100 | 101 | |
| 1,824 | 2,042 | 682 | 1,578 | 544 | -636 | |
| Dividends paid | – | – | – | – | – | – |
| 606 | 128 | 400 | 0 | 1,000 | 1,000 | |
| 57 | 72 | 103 | 115 | 116 | 47 |
Valuation
- 23.1×
- 40.7×
- –
- 2.6×
- 0.2×
- –
- 10.9×
- -5.8%
- 4.3%
- 0.0%
Profitability
- 9.0%
- 1.7%
- 1.0%
- 1.4%
- 7.9%
- 15.8%
- 4.4%
- 1.1%
- 6.4%
- –
Growth
- +18.5%
- −4.5%
- −216.9%
- –
- −3.3%
Financial health
- -0.3×
- 0.97
- 24.1%
- 4.1×
- 1.69
- 1.63
- 2.75
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 39%of 957
Bottom 29%of 889
Top 43%of 601
Top 29%of 884
Bottom 15%of 986
What analysts expect
- Average price target
- $166.09
- Range
- $124.00 – $224.00
- 15 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 22, 2026 | 2.35 | 1.57 | +49.7% |
| Feb 5, 2026 | -2.75 | 0.43 | −739.5% |
| Oct 22, 2025 | 1.84 | 3.97 | −53.7% |
| Jul 23, 2025 | 5.48 | 5.62 | −2.5% |
| Apr 23, 2025 | 6.08 | 5.97 | +1.8% |
| Feb 5, 2025 | 5.05 | 5.74 | −12.0% |
| Oct 23, 2024 | 6.01 | 5.81 | +3.4% |
| Jul 24, 2024 | 5.86 | 5.50 | +6.5% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
39No pass
Benjamin Graham
53No pass
Philip Fisher
42No pass
Peter Lynch
33No pass
Joel Greenblatt
37No pass
Charlie Munger
39No pass
Terry Smith
33No pass
Questions about Molina Healthcare
Is Molina Healthcare a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Molina Healthcare AI analysis
What does Molina Healthcare do?
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. It is in Healthcare Plans, based in Long Beach, CA, United States, with 19,000 employees.
Does Molina Healthcare pay a dividend?
No. Molina Healthcare does not pay a dividend at the moment; in 2025 it returned $1.00 billion to shareholders by buying back its own shares.
Is Molina Healthcare stock halal?
No. Molina Healthcare does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Molina Healthcare stock done over the past year?
Up 48.8% over the past twelve months, to $209.85. It traded between $122.65 and $242.88 and is 13.6% below its high.
Who are Molina Healthcare's competitors?
The largest listed companies in the same industry are UnitedHealth, CVS Health, Elevance Health and The Cigna Group. The peers table on this page compares their profit, growth and price with Molina Healthcare's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.